Dhanvantri Jeevan Rekha Ltd.

View in App
21.95 +0.61 ▲2.9%

23 April 2024, 04:01:00 PM
Volume: 170

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.djrl.org.in
Market Cap 9.00 Cr.
Enterprise Value(EV) 9.00 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.59 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 37.48 Trailing Twelve Months Ending 2023-12
Industry PE 66.00 Trailing Twelve Months Ending 2023-12
Book Value / Share 23.20 Trailing Twelve Months Ending 2023-12
Price to Book Value 0.95 Calculated using Price: 21.95
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.41 Cr. 4,098,400 Shares
FaceValue 10
About Dhanvantri Jeevan Rekha Ltd.
Dhanvantri Jeevan Rekha, incorporated on June 11, 1993 is a multi speciality hospital providing reliable diagnostic and therapeutical services. We lay great emphasis on providing good nursing care and clean environment. Dhanvantri hospital has been on the fore front of providing state of art equipment and services in western UP since 1994.

Dhanvantri Jeevan Rekha Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Dhanvantri Jeevan Rekha Ltd. Performance

View details >>
1 Day
+2.86%
1 Week
+13.26%
1 Month
-10.66%
3 Month
+15.53%
6 Month
+81.26%
1 Year
+49.83%
2 Year
+45.36%
5 Year
+78.46%
10 Year
+33.03%

Dhanvantri Jeevan Rekha Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 14.25 10.75 5.68 7.1 0.44 -2.51 -14.69 5.31 -2.31
Return on Capital Employed (%) 21.14 16.71 11.79 7.91 1.97 -2.55 -16.37 7.4 -1.46
Return on Assets (%) 10.82 7.95 3.77 4.46 0.3 -1.76 -10.03 3.51 -1.54

Dhanvantri Jeevan Rekha Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 8 9 10 11 11 10 9 10 9 9
Non Curr. Liab. 1 1 2 3 1 1 2 2 2 2
Curr. Liab. 2 2 4 3 3 3 3 3 3 4
Minority Int.
Equity & Liab. 11 13 16 16 15 15 14 14 14 14
Non Curr. Assets 7 8 13 13 13 12 11 11 10 10
Curr. Assets 4 4 3 3 3 3 2 4 4 4
Misc. Exp. not W/O
Total Assets 11 13 16 16 15 15 14 14 14 14

Dhanvantri Jeevan Rekha Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 8 9 11 14 17 18 10 17 18 20
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 8 10 12 14 17 18 10 17 18 20
Total Expenditure -6 -8 -10 -12 -16 -18 -11 -15 -17 -19
PBIDT 2 2 2 2 1 1 -1 2 1 1
Interest 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 -1 -1 -1 -1 -1 -1 -1
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 1 1 1 1 0 0 -1 0 0 0
Adjusted EPS 3 2 1 2 0 -1 -3 1 -1 1

Dhanvantri Jeevan Rekha Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1 1 1 4 1 1 1 0 1 0
Cash Fr. Inv. -1 -1 -1 -4 -1 0 0 0 -1
Cash Fr. Finan. 0 0 1 0 -2 0 0 0
Net Change 0 0 0 0 0 -1 1 0 1 -1
Cash & Cash Eqvt 0 0 1 1 1 0 1 1 2 1

Dhanvantri Jeevan Rekha Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 19.77 19.77 19.77 19.77 19.77 19.65 19.65 19.65 19.65
Public 80.23 80.23 80.23 80.23 80.23 80.35 80.35 80.35 80.35
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Dhanvantri Jeevan Rekha Ltd. Announcements

View details >>
Mon, 15 Apr 2024
Compliance Certificate Under 7(3) For The Year Ending March 2024
Complinace certicate under section 7(3) for the year ending March 2024
Mon, 15 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under 74(5) of the SEBI regulation
Fri, 29 Mar 2024
Closure of Trading Window
The trading window of the company will be closed from 1st April 2024 to 48 hours after the board meeting to be held to share disclose the yearly financial results

Dhanvantri Jeevan Rekha Ltd. Technical Scans

View details >>
Tue, 23 Apr 2024
Opening at High Opening at High
Closing Above Previous High Closing Above Previous High
Making Higher Highs for 3 days Making Higher Highs for 3 days
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Decrease in 1 Month High Decrease in 1 Month

Dhanvantri Jeevan Rekha Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 356,001.33 1,484.65 -3.6%
Cipla Ltd. 108,812.62 1,346.70 -0.6%
Divi's Laboratories Ltd. 100,075.02 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. 99,325.26 5,952.10 -1.1%
Zydus Lifesciences Ltd. 96,553.18 959.45 0.0%
Mankind Pharma Ltd. 95,896.87 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. 89,224.37 2,637.40 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 39.97 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 29.34 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 72.36 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.00 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.47 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 55.52 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.72 2,637.40 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.71 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 4.20 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 7.68 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.12 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.79 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.48 2,637.40 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,637.40 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,637.40 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,637.40 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,637.40 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,637.40 +1.8%

Dhanvantri Jeevan Rekha Ltd. FAQ's

What is DhanvantriJeevan Rek share price?
Can I buy DhanvantriJeevan Rek shares now?
What is the Market Cap of DhanvantriJeevan Rek?
What are the key metrics to analyse DhanvantriJeevan Rek?
What is the 52 Week High and Low of DhanvantriJeevan Rek?
What is the trend of DhanvantriJeevan Rek share price?